Design of new potent and selective secretory phospholipase A2 inhibitors. 6 - Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives; ; et al in Bioorganic & Medicinal Chemistry (2010), 18 Detailed reference viewed: 61 (8 ULg) Structure-activity relationships in platelet-activating factor. Part 14: Synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity; ; et al in Bioorganic & Medicinal Chemistry (2006), 14(23), 7999-8013 As HIV-associated dementia prevalence has risen with the lifespan of HIV-infected individuals, there is an important need for antiretroviral and anti-inflammatory drugs targeting the central nervous ... [more ▼] As HIV-associated dementia prevalence has risen with the lifespan of HIV-infected individuals, there is an important need for antiretroviral and anti-inflammatory drugs targeting the central nervous system. Platelet-activating factor, a mediator of inflammation, is an HIV-induced neurotoxin secreted in the infected brain. In this work, we developed piperazine derivatives bearing a heterocyclic moiety as PAF-antagonists and HIV-1 replication inhibitors with micromolar potency. (c) 2006 Elsevier Ltd. All rights reserved. [less ▲] Detailed reference viewed: 29 (2 ULg) Part 13: Synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity; ; et al in Bioorganic & Medicinal Chemistry (2006), 14(23), 8109-8125 HIV-1 infection of the brain and PAF neurotoxicity are implicated in AIDS dementia complex. We previously reported that a trisubstituted piperazine derivative is able to diminish both HIV-1 replication in ... [more ▼] HIV-1 infection of the brain and PAF neurotoxicity are implicated in AIDS dementia complex. We previously reported that a trisubstituted piperazine derivative is able to diminish both HIV-1 replication in monocyte-derived macrophages and PAF-induced platelet aggregation. We report in this work new compounds obtained by modifying its piperazine substituents. The structure-activity relationship study shows that a better dual activity or even pure antiretroviral compounds can be obtained in this series. (c) 2006 Elsevier Ltd. All rights reserved. [less ▲] Detailed reference viewed: 32 (0 ULg) Structure-activity relationships on adrenoceptors and imidazoline-preferring binding sites (I(1,2)-PBSs). Part 1: Weak intramolecular H-bond and conformational flexibility in a new I1-PBS-selective imidazoline analogue, trans1-(4',5'-dihydro-1'H-imidazol-2'-yl)methyl-2-hydroxyindane (PMS 952).; Dive, Georges ; Dehareng, Dominique et alin Bioorganic & Medicinal Chemistry (2000), 8(8), 1861-9 The highly selective I1-PBS imidazoline analogue PMS 952 has been selected to study the incidence of intramolecular hydrogen bond and molecular flexibility on its biological activity. On one hand, the ... [more ▼] The highly selective I1-PBS imidazoline analogue PMS 952 has been selected to study the incidence of intramolecular hydrogen bond and molecular flexibility on its biological activity. On one hand, the weak energy difference between three calculated conformers does not support the stabilization of one conformer by an internal hydrogen bond. The 3-D electrostatic map confirms this feature and the solvent effect does not significantly modify the relative energy of these conformers. On the other hand, the conformational spaces of the neutral and ionized forms present a great number of equilibrium structures, in a short energetic range (20 Kcal). The results are representative of an exceptional conformational flexibility due to a cooperative effect between several parts of the molecule. [less ▲] Detailed reference viewed: 35 (1 ULg) Design and modeling of new platelet-activating factor antagonists.2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkoxymethylpiperazines; ; et al in Journal of Lipid Mediators and Cell Signalling (1996), 15 Detailed reference viewed: 20 (1 ULg) Design and modeling of new platelet-activating factor antagonists.3. Relative importance of hydrophobicity and electronic distribution in piperazinic series; Dive, Georges ; et alin Journal of Lipid Mediators and Cell Signalling (1996), 15(2), 161-173 Detailed reference viewed: 4 (1 ULg) Design and modeling of new PAF antagonists - 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-substituted carbonyloxymethyl piperazines; ; et al in Journal of Lipid Mediators and Cell Signalling (1994), 10(1-2), 153-154 Detailed reference viewed: 3 (1 ULg) Design and modeling of new platelet-activating-factor antagonists.1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines; ; et al in Journal of Medicinal Chemistry (1993), 36(8), 990-1000 Detailed reference viewed: 12 (1 ULg) Paf-Receptor. iii. Conformational and Electronic Properties of Paf-Like Agonists and Antagonists; Dive, Georges ; et alin Biochimica et Biophysica Acta (1991), 1085(1), 91-105 In order to compare electronic and conformational properties of PAF-agonists and PAF-antagonists, 14 analogues structurally related to PAF were studied. A common conformation of the glycerol backbone was ... [more ▼] In order to compare electronic and conformational properties of PAF-agonists and PAF-antagonists, 14 analogues structurally related to PAF were studied. A common conformation of the glycerol backbone was present in all agonists and all constrained or flexible antagonists. The distinction between agonists and antagonists appears to be casted on position-2 where the folded conformation of the substituent for agonists should be the most probable. In position-3 the gauche conformation can be adopted by all the analysed compounds. The electrostatic potential well at -30 kcal/mol stretches to the carbonyl group in position-2 in the folded conformation of the agonists. On the contrary, in constrained antagonists, a second negative zone appears around the carbamate group. Given the modelling results, the triethylammonium PAF analogue considered in literature as a weak agonist, was resynthesized and proved to be more potent than previously reported. These experimental results confirm our hypothesis in terms of a common conformation of agonist and antagonist PAF-like molecules. [less ▲] Detailed reference viewed: 12 (1 ULg) PAF receptor structure: a hypothesis; Dive, Georges ; et alin Lipids (1991), 26(12), 1162-1166 Detailed reference viewed: 8 (2 ULg) PAF receptor and cache-oreilles effect. Simple PAF antagonists; ; Dive, Georges et alin Lipids (1991), 26(12), 1167-1171 Detailed reference viewed: 9 (2 ULg) New hypothesis on the conformation of the PAF receptor from studies on the geometry of selected platelet-activating-factor antagonists; ; et al in Journal of Lipid Mediators (1991), 4(3), 343-346 Detailed reference viewed: 7 (1 ULg) Paf-Receptor. 1. 'Cache-Oreilles' Effect of Selected High-Potency Platelet-Activating Factor (Paf) AntagonistsDive, Georges ; ; et alin Journal of Lipid Mediators (1989), 1(4, Jul-Aug), 201-15 Three-dimensional electrostatic maps were calculated for six potent antagonists of platelet-activating factor (PAF), the antagonists being selected for their apparent structural heterogeneity. The ... [more ▼] Three-dimensional electrostatic maps were calculated for six potent antagonists of platelet-activating factor (PAF), the antagonists being selected for their apparent structural heterogeneity. The molecules examined were the compact Ginkgolides BN 52020, BN 52021 and BN 52022 (1, 2 and 3), the semi-rigid kadsurenone (4), a flexible synthetic dinor type C furanoid lignan L-652,731 (5a) and the triazolothienobenzodiazepine WEB 2086 (7). Calculation of the electrostatic potential generated around all the above molecules showed the existence of two wells of negative potential or 'cache-oreilles' (ear-muffs), i.e., the isocontours drawn at -10 kcal/mol, located at 180 degrees from each other and separated by a maximum distance of 22-27 A. Except for the synthetic dinor type C furanoid lignan (5a), the molecules also presented a moderate hydrophobic fragment, which constitutes a third point of interaction with the high-affinity binding site in rabbit and human platelets. The findings of the present study allow speculation that this high-affinity acceptor site may be a 'polarized cylinder' with a diameter of 10-12 A. [less ▲] Detailed reference viewed: 14 (0 ULg) |
||